1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsOvarian Cancer Detection with Blood- and Imaging-Based Biomarkers is sponsored by National Cancer Institute. Focuses on developing biomarkers for early detection of ovarian cancer using blood and imaging techniques.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Funded Early Detection and Screening Grants | Division of Cancer Prevention Funded Early Detection and Screening Grants Active Grants Completed Grants University Of Tx Md Anderson Can Ctr Blood-Based Biomarkers for Personalized Risk Assessment of Breast and Ovarian Cancer Baylor College Of Medicine BLOOD-BASED PROTEOMIC ASSAY FOR PANCREATIC CANCER DETECTION University Of Pittsburgh At Pittsburgh Blood-Based Testing for Advanced Adenoma University Of Pittsburgh At Pittsburgh Blood-Based Testing for Advanced Adenoma Fred Hutchinson Cancer Center Breast-cancer focused biomarker characterization center employing targeted mass spec assays in a CLIA environment Univ Of North Carolina Chapel Hill Cancer Screening Research Network - North Carolina Hub (CSRN-NC HUB) Elyse LeeVan, M.
D. , M. P.
H. University Of Tx Md Anderson Can Ctr Center for Gastric Pre-Cancer Atlas of Multidimensional Evolution in 3D (GAME3D) Indu Kohaar, Ph. D.
, M. Phil. , M.
Sc. University Of Tx Md Anderson Can Ctr Circulating Biomarkers and Imaging for Early Detection of Pancreatic Cancer University Of Hawaii At Manoa Circulating lipid and miRNA markers for early detection of breast cancer among women with abnormal mammograms Christos Patriotis, Ph. D.
, M. Sc.
University Of California Los Angeles Click Chemistry-Mediated Surface Protein Assay for Quantifying Subpopulations of Hepatocellular Carcinoma-associated Extracellular Vesicles Vanderbilt University Medical Center Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer Vanderbilt University Medical Center Clinical Utility of a Combined Biomarker Approach to Diagnose Lung Cancer Vanderbilt University Medical Center Clinical Utility of Biomarkers Driven Management of Indeterminate Pulmonary Nodules New York University School Of Medicine Clinical Validation Center for Early Detection of Pancreatic Cancer New York University School Of Medicine Clinical Validation Center for Early Detection of Pancreatic Cancer
According to the current listing, eligibility includes: Not specified. Confirm the full requirements in the official notice before applying.
Applications for Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers are due December 31, 2026. Build your timeline backwards from this date to cover registrations, approvals, and final submission checks.
Ovarian Cancer Detection with Blood- and Imaging-Based Biomarkers is funded by National Cancer Institute. Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
The Breast Cancer Research Foundation launched a $100 million venture philanthropy fund at CGI on September 22, 2026, seeded with $23 million and aiming at 20 to 30 companies. Here is what the structure actually means for investigators, for startups in the valley of death, and for every disease foundation now weighing the same move.
Read articleCDC-RFA-DP-27-0023 puts the National Breast and Cervical Cancer Early Detection Program, the National Comprehensive Cancer Control Program, and the National Program of Cancer Registries into a single competition closing February 5, 2027. Three statutorily separate eligibility pools, one application deadline, and an award count that maps onto the incumbent footprint. Here is how to read that.
Read articleCDMRP reissued the FY26 BCRP Breakthrough Award Levels 1 and 2 and the Clinical Research Extension Award on September 3, 2026, with a November 4 pre-application deadline and a November 18 full application deadline. Round one closed July 8. The arithmetic across both windows accounts for nearly the entire FY26 appropriation — which tells you what kind of second chance this is.
Read article